- The agreement will lower out-of-pocket costs for patients
- It will cover Brilinta prescriptions
- Clinical outcomes will determine the level of shared costs between AstraZeneca... read more
MorphoSys AG (FSE: MOR; Prime Standard Segment, MDAX & TecDAX; NASDAQ: MOR) announced on 1/26/19 that it was informed that in its lawsuit against Janssen Biotech and Genmab A/S, the United... read more
Coherus... read more
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,